Investor Relations


Sep 302022 4:24 PM EDT Sep 30, 2022 | 4:24 PM EDT
American Academy of Ophthalmology 2022 Annual Meeting
Sep 122022 11:05 AM EDT Sep 12, 2022 | 11:05 AM EDT
Morgan Stanley 20th Annual Global Healthcare Conference
Sep 122022 8:00 AM EDT Sep 12, 2022 | 8:00 AM EDT
Regeneron ESMO 2022 Investor Event

We are a leading science and technology company that delivers life-transforming medicines for serious diseases.

Founded by physician-scientists more than 30 years ago, our science-driven approach has resulted in nine FDA-approved medicines and numerous product candidates in a range of diseases, including blindness-causing eye diseases, severe inflammatory conditions like asthma and atopic dermatitis, hematologic conditions, pain and infectious diseases such as Ebola and COVID-19.


Analyst Center

Interactive and downloadable financial data for investors and analysts

Contact us

Investor Relations


Media Relations